Invesco Ltd. - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$583,000
-6.1%
575,0000.0%0.00%
Q4 2020$621,000
+4.4%
575,0000.0%0.00%
Q3 2020$595,000
-6.2%
575,0000.0%0.00%
Q2 2020$634,000
-84.0%
575,000
-85.4%
0.00%
-100.0%
Q1 2020$3,973,000
-42.8%
3,925,000
-35.4%
0.00%0.0%
Q4 2019$6,951,000
+0.3%
6,075,0000.0%0.00%0.0%
Q3 2019$6,929,000
+919.0%
6,075,000
+956.5%
0.00%
Q2 2019$680,000
-89.8%
575,000
-88.3%
0.00%
-100.0%
Q1 2019$6,671,000
+26.3%
4,935,0000.0%0.00%0.0%
Q4 2018$5,281,000
+13.4%
4,935,000
+11.3%
0.00%
+100.0%
Q3 2018$4,657,000
-56.8%
4,435,000
-59.6%
0.00%
-75.0%
Q2 2018$10,783,000
+8.3%
10,975,000
+8.9%
0.00%0.0%
Q1 2018$9,953,000
-18.5%
10,075,000
-13.0%
0.00%0.0%
Q4 2017$12,219,000
-0.1%
11,575,0000.0%0.00%
-20.0%
Q3 2017$12,226,000
+0.2%
11,575,000
+0.7%
0.01%
+25.0%
Q2 2017$12,197,000
+10.1%
11,500,0000.0%0.00%0.0%
Q1 2017$11,076,000
-4.5%
11,500,0000.0%0.00%0.0%
Q4 2016$11,593,000
+8.3%
11,500,0000.0%0.00%0.0%
Q3 2016$10,702,000
+31.7%
11,500,0000.0%0.00%
+33.3%
Q2 2016$8,129,000
-40.4%
11,500,000
-23.3%
0.00%
-50.0%
Q1 2016$13,650,000
-19.1%
15,000,0000.0%0.01%
-14.3%
Q4 2015$16,875,00015,000,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2016
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders